Cadence Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-152,428
| Closed | -$2.5M | – | 473 |
|
|
2019
Q4 | $2.5M | Sell |
152,428
-20,084
| -12% | -$330K | 0.27% | 83 |
|
|
2019
Q3 | $2.29M | Sell |
172,512
-6,690
| -4% | -$88.8K | 0.33% | 111 |
|
|
2019
Q2 | $2.53M | Sell |
179,202
-5,984
| -3% | -$84.3K | 0.25% | 117 |
|
|
2019
Q1 | $3.41M | Buy |
185,186
+65,508
| +55% | +$1.21M | 0.31% | 79 |
|
|
2018
Q4 | $3.13M | Sell |
119,678
-55,575
| -32% | -$1.45M | 0.32% | 76 |
|
|
2018
Q3 | $4.02M | Buy |
175,253
+29,234
| +20% | +$671K | 0.22% | 111 |
|
|
2018
Q2 | $2.78M | Buy |
146,019
+42,433
| +41% | +$808K | 0.16% | 142 |
|
|
2018
Q1 | $1.75M | Sell |
103,586
-5,488
| -5% | -$92.5K | 0.11% | 238 |
|
|
2017
Q4 | $1.66M | Buy |
109,074
+46,468
| +74% | +$706K | 0.11% | 255 |
|
|
2017
Q3 | $1.12M | Buy |
+62,606
| New | +$1.12M | 0.07% | 366 |
|